AstraZeneca Raises Full-Year Guidance
Shares of AstraZeneca saw a significant increase in early trade, rising as much as 4.2%, following the company's announcement that it has raised its full-year guidance for core earnings per…
Shares of AstraZeneca saw a significant increase in early trade, rising as much as 4.2%, following the company's announcement that it has raised its full-year guidance for core earnings per…